LotusPress Release: NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression

Press Release: NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression

The first and only tms boca raton approved for use as an adjuvant for patients 15 years of age and above is called NeuroStar.

March 25, 2024, Mavelen, Pa (AMERICA NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a medical technology company, announced that the FDA in the United States has cleared NeuroStar Advanced Therapy for use as an adjuvant for the treatment of major depressive disorder (MDD) in adolescents aged 15 to 21. TMS Boca Raton provides minimally intrusive, very effective therapy for depression with little side effects.Achievement Effective, non-invasive depression therapy is provided by TMS Boca Raton.

Comprehensive mental health services and care are offered by Brandon Mental Health in Brandon, Florida.The company is focused on designing, developing, and marketing products that enhance the quality of life for patients who suffer from neurohealth disorders. This age group is the first for which NeuroStar has received FDA approval as a transcranial magnetic stimulation (TMS) therapy, making it the fourth FDA-approved indication for NeuroStar overall.

“Since the COVID-19 epidemic, the frequency of depression in teenagers and young adults has increased. According to Dr. Kenneth Pages, Medical Director of TMS of South Tampa, “the current treatment options available for adolescents are extremely limited, compared to those available for adults.” With real-world evidence to support it and remarkable response rates that are comparable to adult response rates, NeuroStar’s TMS therapy now presents a potential first-line treatment option for adolescents. This development may lead to a shift in the way that depression in young people is treated.Effective, non-invasive depression treatment with little side effects is provided by TMS Boca Raton.The analysis of real-world data gathered using NeuroStar’s exclusive TrakStar® platform was a contributing factor in the FDA’s decision to approve this additional indication. Important information on the treatment’s safety profile and efficacy in teenagers was made available via this platform. 78% of the 1,169 teenagers in the data analysis saw a clinically significant reduction in the severity of their depression.Depression and anxiety can be treated non-invasively at TMS Boynton Beach.After examining the extensive TrakStar data set and clinical data from the literature, the FDA came to the conclusion that, in this particular population, NeuroStar TMS was essentially as safe and effective as antidepressant therapy when used as an adjuvant. TMS Health Boca Raton provides cutting-edge, non-invasive therapy for anxiety and depression.
For efficient, non-invasive treatment of depression and other mental health issues, look for TMS therapy in my area.Achievement Effective, non-invasive depression therapy is provided by TMS Boca Raton.TMS Health in Boca Raton, FL provides cutting-edge therapy for depression.

 

Leave a Reply

Your email address will not be published. Required fields are marked *

d

Welcome to Reina

Step into a true oasis of digital beauty we devised for your new beauty center, resort or spa website.

Monday to Friday 09:00 - 20:00 hrs
Saturday 09:00 - 18:00 hrs
Sunday 09:00 - 18:00 hrs